Sara Tylosky
Farmacon Global, United States Chief Executive Officer
Experienced Global Executive with over 20 years of leading diverse teams in a fast-paced environments in both big and small pharmas. As CEO at Farmacon Global for the past 10 years, a strategic CRO with medical consultants to accelerate clinical research and market access projects in emerging markets, Sara operates with high cultural intelligence and an established record as an expert problem solver to mobilize successful teams for practical results. With their market focus in Rare Disease, Immunology, Infectious Disease, Cancer & Vaccines, Sara, who has lived on four continents and is fluent in Spanish, has a special focus in Latin America, and is growing other key markets around the globe.